FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+15.82%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.06B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
590
New
73
Increased
137
Reduced
233
Closed
78
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$112M |
| 2 |
DraftKings
DKNG
|
$94.2M |
| 3 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$91.5M |
| 4 |
GE HealthCare
GEHC
|
$82.5M |
| 5 |
GFL Environmental
GFL
|
$82.2M |
Top Sells
| 1 |
Intuit
INTU
|
$196M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$143M |
| 3 |
AbbVie
ABBV
|
$103M |
| 4 |
Walt Disney
DIS
|
$93.9M |
| 5 |
Datadog
DDOG
|
$84.2M |
Sector Composition
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
AT&T
T
$207B
| $1.12M | 0.01% |
70,437
| – | – |
|
377
Personalis
PSNL
$472M
| $1.1M | 0.01% |
584,779
+375,627
| +180% | +$706K |
|
378
MasTec
MTZ
$13.9B
| $1.05M | 0.01% |
+8,932
| New | +$1.05M |
|
|
JBIO
379
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $993K | 0.01% |
1,654
-1,319
| -44% | -$792K |
|
380
Pacific Biosciences
PACB
$375M
| $928K | ﹤0.01% |
+69,780
| New | +$928K |
|
|
381
Walt Disney
DIS
$214B
| $883K | ﹤0.01% |
9,891
-1,051,840
| -99% | -$93.9M |
|
382
RxSight
RXST
$366M
| $878K | ﹤0.01% |
+30,491
| New | +$878K |
|
383
Spotify
SPOT
$148B
| $824K | ﹤0.01% |
5,133
-13,565
| -73% | -$2.18M |
|
384
American Express
AXP
$226B
| $820K | ﹤0.01% |
4,706
| – | – |
|
385
Zoetis
ZTS
$67.3B
| $772K | ﹤0.01% |
4,484
-22,961
| -84% | -$3.95M |
|
386
Accenture
ACN
$159B
| $743K | ﹤0.01% |
2,407
| – | – |
|
|
IMGN
387
DELISTED
Immunogen Inc
IMGN
| $729K | ﹤0.01% |
+38,658
| New | +$729K |
|
388
Autodesk
ADSK
$69.6B
| $651K | ﹤0.01% |
3,184
| – | – |
|
389
Akero Therapeutics
AKRO
$3.57B
| $644K | ﹤0.01% |
+13,783
| New | +$644K |
|
390
Agilent Technologies
A
$36.3B
| $609K | ﹤0.01% |
5,063
-32,889
| -87% | -$3.95M |
|
391
Protagonist Therapeutics
PTGX
$3.5B
| $600K | ﹤0.01% |
21,719
+10,114
| +87% | +$279K |
|
392
Deere & Co
DE
$130B
| $596K | ﹤0.01% |
1,471
-95
| -6% | -$38.5K |
|
|
DADA
393
DELISTED
Dada Nexus
DADA
| $584K | ﹤0.01% |
+110,000
| New | +$584K |
|
394
Aptiv
APTV
$17.9B
| $580K | ﹤0.01% |
5,682
| – | – |
|
395
New Oriental
EDU
$8.19B
| $573K | ﹤0.01% |
14,500
-4,000
| -22% | -$158K |
|
396
Tetra Tech
TTEK
$9.38B
| $549K | ﹤0.01% |
16,770
-1,930
| -10% | -$63.2K |
|
397
Twist Bioscience
TWST
$1.58B
| $544K | ﹤0.01% |
+26,587
| New | +$544K |
|
398
Rockwell Automation
ROK
$38.8B
| $528K | ﹤0.01% |
1,603
| – | – |
|
399
Xylem
XYL
$34.1B
| $518K | ﹤0.01% |
4,601
-1,165
| -20% | -$131K |
|
400
Synopsys
SNPS
$113B
| $492K | ﹤0.01% |
1,130
-94
| -8% | -$40.9K |
|